🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an 8-week, double-blind, randomized placebo-controlled trial of the...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2023-04-18
Trial ID
NCT05262270
A single center, open-label SUBLOCADE treatment extension study in which up...
Status
Completed
Location
Hassman Research Institute
Start Date
2019-10-21
Trial ID
NCT04060654
Treatments Being Tested
This study seeks to compare the effectiveness of two medications used to tr...
Status
Completed
Location
Yale University School of Medicine
Start Date
2021-01-07
Trial ID
NCT04219540
Treatments Being Tested
This is a multiple-dose study in non-treatment seeking male and female subj...
Status
Completed
Location
Vince & Associates Clinical Research
Start Date
2013-11
Trial ID
NCT02044094
Treatments Being Tested
Opioid use disorder and opioid-related deaths are increasing across Canada....
Status
Unknown
Location
Royal Victoria Regional Health Centre
Start Date
2022-12
Trial ID
NCT05594121
Treatments Being Tested
This exploratory project will assess the acceptability and feasibility of m...
Status
Not Yet Recruiting
Location
Yale School of Medicine
Start Date
2026-08
Trial ID
NCT07176351
Treatments Being Tested
This is a sub-study of NIDA CTN Protocol 0080: Medication Treatment for Opi...
Status
Completed
Location
Gateway Community Services
Start Date
2020-07-21
Trial ID
NCT03911466
Treatments Being Tested
This is a pilot proof-of-concept randomized controlled trial, open-label an...
Status
Completed
Location
Bellevue Hospital Center
Start Date
2019-06-24
Trial ID
NCT03604159
The study objective is to characterise the long-term plasma exposure to bup...
Status
Completed
Location
Pathway Healthcare
Start Date
2019-02-19
Trial ID
NCT03752528
Treatments Being Tested
Extended-release buprenorphine (SUBLOCADE®) injection is currently approved...
Status
Completed
Location
Artemis Institute for Clinical Research
Start Date
2023-03-01
Trial ID
NCT05704543
Treatments Being Tested